Anticipate generic drug launch
Proactively manage your pharmacy inventory
Manage your formulary budget
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Inhibitors for replication of retroviruses and for the expression of oncogene products|
|Abstract:||Phosphorothioate oligodeoxyribonucleotide analogs can be used to prevent replication of foreign nucleic acids in the presence of normal living cells, as well as to inhibit the proliferation of neoplastic cells.|
|Inventor(s):||Cohen; Jack S. (Bethesda, MD), Neckers; Len (Bethesda, MD), Stein; Cy (Gaithersburg, MD), Loke; She L. (Wheaton, MD), Shinozuka; Kazuo (Kazo, JP)|
|Assignee:||The United States of America as represented by the Department of Health (Washington, DC)|
Patent Claim Types:|
see list of patent claims
|Use; Compound; Composition;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||0288163||<disabled in preview>|
|Germany||3852714||<disabled in preview>|
|Canada||1322723||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.